Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASH
Public ClinicalTrials.gov record NCT06054815. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel, Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed Non-alcoholic Steatohepatitis (NASH)
Study identification
- NCT ID
- NCT06054815
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- NeuroBo Pharmaceuticals Inc.
- Industry
- Enrollment
- 109 participants
Conditions and interventions
Conditions
Interventions
- DA-1241 Drug
- DA-1241 Placebo Drug
- Sitagliptin Drug
- Sitagliptin Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 13, 2023
- Primary completion
- Oct 23, 2024
- Completion
- Oct 29, 2024
- Last update posted
- Nov 13, 2024
2023 – 2024
United States locations
- U.S. sites
- 18
- U.S. states
- 6
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Southern California Research Center | Coronado | California | 92118 | — |
| Catalina Research Institute, LLC | Montclair | California | 91763 | — |
| Velocity Clinical Research, Panorama City | Panorama City | California | 91402 | — |
| Inland Empire Clinical Trials, LLC | Rialto | California | 92377 | — |
| Integrity Clinical Research, LLC | Doral | Florida | 33122 | — |
| Clinical Pharmacology of Miami, LLC | Miami | Florida | 33014 | — |
| Suncoast Research Group, LLC | Miami | Florida | 33135 | — |
| Floridian Clinical Research | Miami Lakes | Florida | 33016 | — |
| GI Associates & Endoscopy Center | Flowood | Mississippi | 39232 | — |
| AIG Digestive Disease Research | Florham Park | New Jersey | 07932 | — |
| South Texas Research Institute - A Pinnacle Entity | Edinburg | Texas | 78539 | — |
| Dallas Research Institute, LLC | Farmers Branch | Texas | 75234 | — |
| Pinnacle Clinical Research - Georgetown | Georgetown | Texas | 78626 | — |
| Pioneer Research Solutions Inc. | Houston | Texas | 77099 | — |
| American Research Corporation | San Antonio | Texas | 78215 | — |
| Pinnacle Clinical Research - San Antonio | San Antonio | Texas | 78229 | — |
| Apex Mobile Clinical Research, LLC | San Antonio | Texas | 78258 | — |
| Liver Institute Northwest | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06054815, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 13, 2024 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06054815 live on ClinicalTrials.gov.